PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dartmouth-led project updates smoking as a risk factor in NCI mortality estimates

2023-06-12
(Press-News.org)

New findings from a project led by researchers at Dartmouth’s Geisel School of Medicine in collaboration with the National Cancer Institute (NCI) and published in the journal JAMA Network Open, show the dramatic impact that smoking status has on mortality and more accurately predict the risk of dying from cancer and other diseases.

 

“Historically, mortality risk has often been presented by age, sex, and race but it rarely has accounted for smoking status—a major risk factor for many causes of death,” says lead author Steven Woloshin, MD, MS, a professor of medicine and community and family medicine, and co-director of the Master of Health Care Delivery Science program at The Dartmouth Institute for Health Policy and Clinical Practice. “Our main goal has been to address this important gap in mortality estimates.”

 

The project involved updating the NCI’s Know Your Chances website, which allows users to create interactive risk charts with age, sex, and race-specific estimates of the probability of death from 88 different causes that are now stratified by smoking status across variable timeframes. 

 

The researchers found that the chance of death from major causes like heart disease, lung cancer, and all-causes combined vary importantly by smoking status. 

 

For example, after age 40 the observed effect of never vs. current smoking on the 10-year chance of death from all causes combined approximates adding 10 years to a smoker’s age. Similarly, after age 40, the chance of death from all causes combined also varied importantly by race—adding about 5 years to a Black person’s age compared to a White person with the same smoking status.

 

In 2015, Woloshin and his wife and research partner Lisa Schwartz, MD, MS (who passed away in 2018) worked with the NCI to create the Know Your Chances website to provide a free public resource for patients and their physicians, researchers, policy makers, journalists, and others. 

 

“The aim of the website has been to help people make sense of the disease 

risks they face by providing basic facts and context—including how big the risks are and how they compare with each other,” he says.

 

Woloshin and his colleagues developed the updated mortality estimates using life-table methodology (via the NCI’s DevCan software package), combining data from multiple sources such as the U.S. National Vital Statistics System. 

 

“This project shows that the initial intuition we had was true—that failing to account for smoking results in inaccurate estimates for many causes of death, consistently underestimating the risk for smokers and overestimating the risk for non-smokers,” says Woloshin. 

 

“We’re totally open and enthusiastic about getting advice or suggestions from the public,” he adds. “We want to make the updated Know Your Chances website as useful as possible to its various audiences.”

 

The Dartmouth Institute for Health Policy and Clinical Practice is a world leader in studying and advancing models for disruptive change in healthcare delivery. The work of Dartmouth Institute faculty and researchers includes developing the concept of shared decision-making between patients and healthcare professionals, creating the model for Accountable Care Organizations (ACOs), and introducing the game-changing concept that more healthcare is not necessarily better care.

 

# # #

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Victor J. Torres, Ph.D., named chair of newly formed Department of Host-Microbe Interactions at St. Jude Children’s Research Hospital

Victor J. Torres, Ph.D., named chair of newly formed Department of Host-Microbe Interactions at St. Jude Children’s Research Hospital
2023-06-12
(MEMPHIS, Tenn., June 12, 2023) St. Jude Children’s Research Hospital today announced that Victor J. Torres, Ph.D., an internationally renowned microbiologist and immunologist has been selected as the inaugural chair of a new Department of Host-Microbe Interactions. This department will establish a world-leading effort focused on exploring the fundamental biology of the interaction of infectious agendas with the human host. The discoveries made through this new effort will advance our ability to more effectively treat, as well as prevent infectious diseases “Infectious diseases remain one of the leading causes of death globally for children under the age of five,” ...

Digital divide hinders rural innovation, study shows

2023-06-12
UNIVERSITY PARK, Pa. — Cloud-based computing directly contributes to business innovation, but rural businesses lacking sufficient broadband capacity to access cloud services are missing out on their innovation-boosting potential, according to a team of researchers from Penn State and the National Science Foundation. The findings can be used by policymakers and business-support organizations to foster greater opportunities for rural innovation.  “Innovation plays a critical role in keeping businesses competitive and viable, and in turn, healthy businesses are essential to vibrant rural economies. Therefore, we’re interested ...

Penile HIV infection is effectively prevented by antiretroviral treatment

2023-06-12
Of the 38 million people worldwide living with HIV, approximately 700,000 are newly infected men, primarily via sexual transmission. Sexually transmitted HIV infections in exclusively heterosexual men are acquired through the penis. In addition, semen which is produced in the male genital tract (MGT) has been recognized as the primary vector for vaginal and rectal HIV transmission. Notably, the risk of sexual HIV transmission increases with the presence of a concurrent sexually transmitted infection. For the majority of patients, antiretroviral therapy (ART) rapidly decreases the viral load in blood and semen, ...

Breakthrough in glioblastoma treatment with the help of a virus

Breakthrough in glioblastoma treatment with the help of a virus
2023-06-12
In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program at Huntsman Cancer Institute, identified a potential breakthrough in glioblastoma treatment. Glioblastoma, or GBM, is an aggressive type of brain cancer. According to Colman, this is the most common type of cancerous brain tumor in adults. Standard treatments include radiation and chemotherapy. Unfortunately, typical GBM tumors are often resistant ...

AMA strengthens its policy on protecting access to gender-affirming care

2023-06-12
CHICAGO—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to protect access to evidence-based gender-affirming care for transgender and gender-diverse individuals. As political attacks on gender-affirming care escalate, it is the responsibility of the medical community to speak out in support of evidence-based care. Medical decisions should be made by patients, their relatives and health care providers, not politicians. In the resolution, the AMA committed to opposing any criminal and legal penalties against patients seeking ...

Even with insurance, many patients with diabetes turn to GoFundMe to offset high cost of care

2023-06-12
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0540 URL goes live when the embargo lifts An analysis of medical crowdfunding campaigns reveals the types of expenses that patients with diabetes may struggle to afford. The data showed that even insured patients with diabetes used GoFundMe to offset the excess costs of treatment beyond insulin, such as uncovered co-pays, indirect care, and alert dogs. The findings are published in Annals of Internal Medicine. More than 40% of patients with diabetes in the United States have trouble ...

Working hard for money decreases consumers’ willingness to risk their earnings, study shows

2023-06-12
Studies show that consumers believe people who work hard for their money have higher incomes, are more financially literate and are more comfortable taking on prudent financial risk.  Similarly, national survey data used by policymakers to assess the relationship between effortful earning and financial risk-taking also shows a positive correlation between the two.  While, at the population level this may be true, new research from the University of Notre Dame shows that the harder an individual ...

Four-legged robot traverses tricky terrains thanks to improved 3D vision

2023-06-12
Researchers led by the University of California San Diego have developed a new model that trains four-legged robots to see more clearly in 3D. The advance enabled a robot to autonomously cross challenging terrain with ease—including stairs, rocky ground and gap-filled paths—while clearing obstacles in its way. The researchers will present their work at the 2023 Conference on Computer Vision and Pattern Recognition (CVPR), which will take place from June 18 to 22 in Vancouver, Canada. “By providing the robot with a better understanding of its surroundings in 3D, it can be deployed in more complex environments ...

Researcher explores vulnerabilities of AI systems to online misinformation

Researcher explores vulnerabilities of AI systems to online misinformation
2023-06-12
A University of Texas at Arlington researcher is working to increase the security of natural language generation (NLG) systems, such as those used by ChatGPT, to guard against misuse and abuse that could allow the spread of misinformation online. Shirin Nilizadeh, assistant professor in the Department of Computer Science and Engineering, has earned a five-year, $567,609 Faculty Early Career Development Program (CAREER) grant from the National Science Foundation (NSF) for her research. Understanding the vulnerabilities of artificial intelligence (AI) to online misinformation is “an important and timely problem to address,” ...

Food-drug interactions could be impactful for some lung cancer patients according to new study in JNCCN

Food-drug interactions could be impactful for some lung cancer patients according to new study in JNCCN
2023-06-12
PLYMOUTH MEETING, PA [June 12, 2023] — New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to treat some types of advanced lung cancer—was taken with a fuller breakfast, or with lunch, it resulted in significantly higher drug concentrations than when taken with a low-fat breakfast. The researchers, based out of Rotterdam, The Netherlands, evaluated 20 randomized patients who took one of two daily alectinib doses with either low-fat yogurt ...

LAST 30 PRESS RELEASES:

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall

Emerging alternatives to reduce animal testing show promise

Presenting Evo – a model for decoding and designing genetic sequences

Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions

Industrial snow: Factories trigger local snowfall by freezing clouds

Backyard birds learn from their new neighbors when moving house

New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050

Breakthrough in capturing 'hot' CO2 from industrial exhaust

New discovery enables gene therapy for muscular dystrophies, other disorders

Anti-anxiety and hallucination-like effects of psychedelics mediated by distinct neural circuits

[Press-News.org] Dartmouth-led project updates smoking as a risk factor in NCI mortality estimates